CFDA: FDA Latest Computer Systems Warning Letters

WL Issued to Amrex Zetron Inc
FDA Tue, 14 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Amrex Zetron Inc on 14 Apr 2009 by Los Angeles District Office
WL Issued to Coast Institutional Review Board
FDA Tue, 14 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Coast Institutional Review Board on 14 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Branitz, Bruce, MD
FDA Thu, 09 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Branitz, Bruce, MD on 09 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Cote, Charles J., MD
FDA Mon, 02 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Cote, Charles J., MD on 02 Mar 2009 by Center for Drug Evaluation and Research
WL Issued to Genzyme Corporation
FDA Fri, 27 Feb 2009 00:00:00 -0400
FDA Warning Letter Issued to Genzyme Corporation on 27 Feb 2009 by New England District Office
WL Issued to Hammill Manufacturing Company
FDA Tue, 06 Jan 2009 00:00:00 -0400
FDA Warning Letter Issued to Hammill Manufacturing Company on 06 Jan 2009 by Cincinnati District Office

CFDA: FDA Latest Drug GCP Warning Letters

WL Issued to Coast Institutional Review Board
FDA Tue, 14 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Coast Institutional Review Board on 14 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Branitz, Bruce, MD
FDA Thu, 09 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Branitz, Bruce, MD on 09 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Bukowski, Ronald M, MD
FDA Mon, 30 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Bukowski, Ronald M, MD on 30 Mar 2009 by Center for Drug Evaluation and Research
WL Issued to Youabian, Inc
FDA Tue, 17 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Youabian, Inc on 17 Mar 2009 by Los Angeles District Office
WL Issued to Provena St. Joseph's Medical Center IRB
FDA Thu, 12 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Provena St. Joseph's Medical Center IRB on 12 Mar 2009 by Center for Biologics Evaluation and Research
WL Issued to Paulson, Daniel M., MD
FDA Wed, 11 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Paulson, Daniel M., MD on 11 Mar 2009 by Center for Drug Evaluation and Research

 

Subscribe to Drugs_and_Medications RSS feed

DrugDigest: Budesonide Inhaler (Pulmicort) - Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.

Pulmicort - Pharmacy facts and dosage information.

Pulmicort Respules - A corticosteroid inhalation suspension generally prescribed for children 12 months to 8 years of age. Features product information, prescribing information, asthma overview, and details of their Kids Unlimited patient program.
Meta Description: [ PULMICORT RESPULES is one of the pediatric asthma medications available today. Learn about its usage, effectiveness, and safety at PulmicortRespules.com ]

Pulmicort Respules - Drug and asthma management resources for US health care professionals. Includes drug information, patient materials, and prescribing information.

Pulmicort Turbuhaler - Features information about how to use the drug, full prescribing information for US residents, and a glossary as well as asthma information and resources.
Meta Description: [ The web site for Pulmicort Turbuhaler (R) (budesonide inhalation powder): Your on-line resource for information on asthma and treatment with PULMICORT TURBUHALER. ]

Pulmicort Turbuhaler Asthma Resource Center - Drug and asthma information for US health care professionals. Includes prescribing information, professional resources, patient materials, and FAQs.
Meta Description: [ The PULMICORT TURBUHALER web site, your source for clinical information about PULMICORT TURBUHALER, as well as resources to help your patients manage their asthma. ]

Symbicort - AstraZeneca International - An asthma treatment consisting of the inhaled corticosteroid budesonide together with the rapid- and long-acting ß2-agonist formoterol. Not available in US.
Meta Description: [ Symbicort is a revolutionary medication in inhaled asthma therapy that can quickly gain asthma control with both budesonide and formoterol medicine in single inhalers, and is approved for the treatment of COPD. ]